ValiRx PLC (VALX.L)

VALX.L on London Stock Exchange

0.22GBp
19 Dec 2014
Price Change (% chg)

0.00p (+0.00%)
Prev Close
0.22p
Open
0.22p
Day's High
--
Day's Low
--
Volume
104,139,905
Avg. Vol
33,375,685
52-wk High
0.54p
52-wk Low
0.18p

VALX.L

Chart for VALX.L

About

ValiRx Plc is an investment holding Company. The Company is engaged in developing technologies and products in oncology therapeutics and diagnostics. The Company focuses on the treatment of cancer, specialising in epigenomic and genetic analysis. Its technologies and products are also applied to other fields, such as neurology... (more)

Overall

Beta: 0.94
Market Cap (Mil.): £6.47
Shares Outstanding (Mil.): 2,941.38
Dividend: --
Yield (%): --

Financials

  VALX.L Industry Sector
P/E (TTM): -- 180.08 38.03
EPS (TTM): -0.00 -- --
ROI: -64.58 -0.62 18.26
ROE: -63.74 -1.77 19.16
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Sadif Analytics Prime
$25.00
Provider: GlobalData
$250.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks